Rocket


News + Filings
Transactions





GOWEN MAXINE

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
08/10/2023Aceragen, Inc.IDRASaleCommon Stock51$0.51$26By Trust08/10/2023
06/08/2023Merus N.V.MRUSGrantShare option (right to buy)14.4k$23.29$335.7k 06/08/2023
06/02/2023Aclaris Therapeutics, Inc.ACRSExerciseRestricted Stock Units4.5k$0.00$0 06/01/2023
06/01/2023Aclaris Therapeutics, Inc.ACRSGrantRestricted Stock Units4.7k$0.00$0 06/01/2023
06/01/2023Aclaris Therapeutics, Inc.ACRSGrantStock Option (Right to Buy)15.8k$8.70$137k 06/01/2023
05/25/2023Passage BIO, Inc.PASGGrantDirector Stock Option (Right to Buy)24k$1.00$24k 05/25/2023
06/23/2022Aceragen, Inc.IDRAGrant 26k$0.46$11.9k 06/23/2022
06/03/2022Aclaris Therapeutics, Inc.ACRSExerciseRestricted Stock Units3.4k$0.00$0 06/02/2022
06/02/2022Aclaris Therapeutics, Inc.ACRSGrantStock Option (Right to Buy)15.8k$14.48$228.1k 06/02/2022
06/02/2022Aclaris Therapeutics, Inc.ACRSGrantRestricted Stock Units4.5k$0.00$0 06/02/2022
05/31/2022Passage BIO, Inc.PASGGrantStock Option (Right to Buy)40k$1.80$72k 05/31/2022
05/31/2022Merus N.V.MRUSGrantShare option (right to buy)16.6k$18.56$308.2k 05/31/2022
05/26/2022Passage BIO, Inc.PASGGrantDirector Stock Option (Right to Buy)24k$1.76$42.2k 05/26/2022
06/08/2021Aceragen, Inc.IDRAGrant 26k$1.31$34.1k 06/08/2021
06/03/2021Aclaris Therapeutics, Inc.ACRSGrantStock Option (Right to Buy)12.2k$21.90$268.3k 06/03/2021
06/03/2021Aclaris Therapeutics, Inc.ACRSGrantRestricted Stock Units3.4k$0.00$0 06/03/2021
05/28/2021Merus N.V.MRUSGrantShare option (right to buy)12.2k$21.15$258.9k 05/28/2021
05/28/2021Merus N.V.MRUSGrantShare option (right to buy)12.2k$21.15$258.9k 05/28/2021
05/27/2021Passage BIO, Inc.PASGGrantDirector Stock Option (Right to Buy)4.5k$13.83$62.8k 05/27/2021
02/18/2021Passage BIO, Inc.PASGGrantStock Option (right to buy)33.8k$21.46$726.1k 02/18/2021
06/08/2020Akebia Therapeutics, Inc.AKBASaleCommon Stock4.6k$12.05$55k 06/05/2020
06/05/2020Akebia Therapeutics, Inc.AKBAGrantStock Option (Right to buy)20.1k$11.96$240.4k 06/05/2020
06/05/2020Akebia Therapeutics, Inc.AKBAGrantCommon Stock13.7k$0.00$0 06/05/2020
06/04/2020Aclaris Therapeutics, Inc.ACRSGrantOption Grant (right to buy)16.5k$1.41$23.3k 06/04/2020
05/13/2020TREVENA INCTRVNGrantStock Option (Right to Buy)64.1k$1.05$67.3k 05/13/2020
05/12/2020Aceragen, Inc.IDRAGrant 11.5k$1.97$22.7k 05/12/2020
03/02/2020Aclaris Therapeutics, Inc.ACRSExerciseRestricted stock units4.4k$0.00$0 03/02/2020
03/02/2020Aclaris Therapeutics, Inc.ACRSGrantRestricted stock units4.4k$0.00$0 03/02/2020
07/02/2019Aclaris Therapeutics, Inc.ACRSGrantStock option (right to buy)16k$2.34$37.4k 07/02/2019
06/06/2019Akebia Therapeutics, Inc.AKBAGrantCommon Stock13.7k$0.00$0 06/06/2019
06/06/2019Akebia Therapeutics, Inc.AKBAGrantStock Option (Right to buy)20.1k$4.23$85k 06/06/2019
06/04/2019Aceragen, Inc.IDRAGrant 11.5k$2.57$29.6k 06/04/2019
05/16/2019TREVENA INCTRVNGrantStock Option (Right to Buy)30k$1.34$40.2k 05/16/2019
02/01/2019TREVENA INCTRVNPurchaseCommon Stock50k$1.02$51k 02/01/2019
06/20/2018Aceragen, Inc.IDRAGrant 50k$1.53$76.5k 06/20/2018
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy